Exos Asset Management’s Biote Corp. Warrant BTMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1K Sell
1,329
-19,389
-94% -$10.5K ﹤0.01% 298
2022
Q1
$11K Hold
20,718
﹤0.01% 299
2021
Q4
$15K Hold
20,718
0.01% 329
2021
Q3
$17K Hold
20,718
0.01% 381
2021
Q2
$22K Buy
+20,718
New +$17.9K 0.01% 685

Other funds holding BTMDW

Exos Asset Management's BTMDW Position: Q2 2022 in Review

Exos Asset Management reduced its Biote Corp. Warrant (BTMDW) stake by 94% in Q2 2022, selling an estimated $10.5K and leaving 1,329 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #298.

Exos Asset Management first reported a position in BTMDW in Q2 2021 and has held it in 5 quarters since. The position peaked at $22K in Q2 2021. 42 funds tracked by Wall St. Rank hold BTMDW as of Q2 2022.

  • Exos Asset Management held 1,329 shares of Biote Corp. Warrant worth $1K as of Q2 2022.
  • Exos Asset Management sold 19,389 Biote Corp. Warrant shares in Q2 2022, an estimated $10.5K.
  • Biote Corp. Warrant made up ﹤0.01% of Exos Asset Management's portfolio in Q2 2022, its #298 holding.
  • Exos Asset Management first reported a position in Biote Corp. Warrant in Q2 2021 and has held it in 5 quarters since.
  • Exos Asset Management's Biote Corp. Warrant position peaked at $22K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.